248
Participants
Start Date
August 31, 2008
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
fluorouracil
Given IV
leucovorin calcium
Given IV
oxaliplatin
Given IV
conventional surgery
Patients undergo surgery
radiation therapy
Patients undergo radiotherapy
laboratory biomarker analysis
Correlative studies
DNA analysis
Correlative studies
polymerase chain reaction
Correlative studies
immunohistochemistry staining method
Correlative studies
Washington Cancer Institute at Washington Hospital Center, Washington D.C.
Cleveland Clinic Taussig Cancer Center, Cleveland
Masonic Cancer Center at University of Minnesota, Minneapolis
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis
Colon and Rectal Surgery, Incorporated, Omaha
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Cancer Care Center at John Muir Health - Concord Campus, Concord
City of Hope Medical Center, Duarte
St. Joseph Hospital Regional Cancer Center - Orange, Orange
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa
University of Chicago Cancer Research Center, Chicago
Knight Cancer Institute at Oregon Health and Science University, Portland
Vermont Cancer Center at University of Vermont, Burlington
Tom Baker Cancer Centre - Calgary, Calgary
National Cancer Institute (NCI)
NIH
Memorial Sloan Kettering Cancer Center
OTHER